Skip to main content
KOWA CO.,LTD. logo

KOWA CO.,LTD. — Investor Relations & Filings

Ticker · 7807 ISIN · JP3292900002 LEI · 353800AVPSFI46030813 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-04-06 Regulatory Filings
Country JP Japan
Listing T 7807

About KOWA CO.,LTD.

https://www.kowa.co.jp/eng/

Kowa Co., Ltd. is a diversified company that integrates manufacturing and trading operations across several business units. The company's trading arm manages the import, export, and sale of a wide range of products, including textiles, machinery, and construction materials. In the life science and healthcare sector, Kowa develops, manufactures, and markets pharmaceuticals, over-the-counter health products, and medical devices, with a notable specialization in ophthalmic diagnostic equipment. The company is also a prominent manufacturer of high-performance optical products, such as binoculars and spotting scopes, under its Prominar brand. Additionally, Kowa operates a hospitality business, managing hotels and other related services.

Recent filings

Filing Released Lang Actions
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
Regulatory Filings Classification · 85% confidence The document is a press release announcing non-clinical data and an upcoming scientific presentation at the AACR Annual Meeting. It contains no financial results, governance changes, share transactions, or other structured regulatory filings. It is not an investor presentation or management report; rather it is a general corporate news announcement. Therefore, it falls into the fallback category for miscellaneous regulatory announcements (RNS).
2026-04-06 English
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. It accompanies the Second Quarter Report (第２四半期報告書) to confirm the accuracy of the financial statements. Since this is a regulatory filing required by law to accompany financial reports and does not fit into specific categories like earnings releases or annual reports, it is classified as a Regulatory Filing (RNS).
2025-10-15 Japanese
半期報告書－第39期(2025/03/01－2026/02/28)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for KOWA CO., LTD. for the period ending August 31, 2025. It contains detailed financial statements, management analysis (MDA), and corporate information, which are characteristic of an interim financial report. It is not an announcement of a report (RPA) as it contains the full financial data and disclosures required by the Financial Instruments and Exchange Act of Japan. H1 2026
2025-10-15 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document text contains the Japanese header "訂正有価証券報告書（通常方式）" which translates to "Amended Securities Report (Regular Form)". It references the Financial Instruments and Exchange Act ("金融商品取引法") and is submitted to the Kinki Local Finance Bureau Director ("近畿財務局長"). A Securities Report (Yuka Shoken Hokokusho) in the US context is equivalent to a 10-K or 10-Q. Since this is an *amended* report confirming the appropriateness of the contents for a specific fiscal period (Year 38, ending Feb 28, 2025), it relates directly to the official annual filing. However, none of the provided codes perfectly match a Japanese 'Amended Securities Report'. The closest equivalent for a comprehensive annual filing is '10-K'. Given the context of official regulatory filings concerning annual performance confirmation, '10-K' is the most appropriate classification among the choices, representing the core annual disclosure document being amended. The document length is short, but it is the report itself (or an amendment to it), not an announcement *about* the report's publication, thus RPA/RNS is less appropriate than classifying the nature of the underlying document being confirmed. FY 2025
2025-06-05 Japanese
訂正有価証券報告書－第38期(2024/03/01－2025/02/28)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (訂正有価証券報告書) for an Annual Securities Report (有価証券報告書). In the Japanese regulatory context, the '有価証券報告書' is the equivalent of the 10-K (Annual Report). The document contains detailed financial data, XBRL tags, and management information for the 38th fiscal year. Since it is a formal filing of the annual report (even if a correction), it falls under the 10-K category. FY 2025
2025-06-05 Japanese
内部統制報告書－第38期(2024/03/01－2025/02/28)
Audit Report / Information Classification · 98% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Financial Instruments and Exchange Act Article 24-4-4, Paragraph 1). This structure and content—evaluating the effectiveness of internal controls over financial reporting as of a specific fiscal year-end (2025年２月28日)—is characteristic of an internal control report required under Japanese financial regulations. While Japan does not have a direct equivalent to the US SEC's 10-K integrated audit report, the closest classification among the provided options that deals with formal, comprehensive internal control assessment and reporting, especially when it's a standalone report, is the Audit Report / Information (AR), as it covers internal control evaluation results. It is not an Annual Report (10-K) as it is specifically focused on internal controls, not the full financial performance narrative. It is also not an Earnings Release (ER) or Interim Report (IR) as it is a specific compliance document. FY 2025
2025-05-29 Japanese

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.